The markets are in the early stages of pricing in stagflation. Here’s what happens next.
source: marketwatch_top
sentiment: -0.70 · impact: 0.80
source: marketwatch_top
sentiment: -0.70 · impact: 0.80
oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint
kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international
the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out
ai chipmaker cerebras filed for an ipo on the nasdaq, aiming to raise up to $3.5 billion. it plans to sell 28 million shares at $115 to $125 each, which could value the company at $26.6 billion. that's up from a $23 billion valuation in a